Based on the data provided, the sales values (in US Dollars PPP Per Capita) for the years are:
- 2024: 41
- 2025: 41.1
- 2026: 41.2
- 2027: 41.3
- 2028: 41.3
The year-on-year variation percentages are:
- 2025: 0.24%
- 2026: 0.24%
- 2027: 0.24%
- 2028: 0%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately 0.18%.
As the market for alimentary tract and metabolism medicines in Australia demonstrates a modest but stable growth pattern, future trends to watch include advancements in medication technology, increased prevalence of metabolic disorders, and policy changes in healthcare funding. Monitoring these factors will be crucial for predicting market dynamics.
